Sjogren's Syndrome is a rare autoimmune disease with limited treatment optionsPrior U.S. Phase 3 data demonstrated benefitsSAN DIEGO, CA / ACCESSWIRE / September 24, 2024 / Ainos, Inc.
This press release replaces the release issued today at 9:15am EDT.Revolutionary AI-driven cheek swab test poised to transform early cancer detection with continuously improving accuracy. Revealia™ ...
QUAKERTOWN, PA / ACCESSWIRE / September 24, 2024 / At the start of 2024, DEXIS introduced its digital ecosystem, a suite of tools and software designed to connect and streamline the implant workflow ...
QUAKERTOWN, PA / ACCESSWIRE / September 24, 2024 / At the start of 2024, DEXIS introduced its digital ecosystem, a suite of tools and software designed to connect and streamline the implant workflow ...
Revolutionary AI-driven cheek swab test poised to transform early cancer detection with continuously improving accuracy. Revealia™: A Breakthrough in Cancer Detection through Advanced AI and Machine ...
GRAND RAPIDS, MI / ACCESSWIRE / September 24, 2024 / SpendMend, the leading provider of cost-cycle management solutions for ...
A New Standard for Precision in Patient Care ForecastingBOSTON, MA / ACCESSWIRE / September 24, 2024 / In a significant breakthrough in healthcare AI, GenHealth.ai today published a study detailing an ...
Criteria updates include new Digital Therapeutics program criteria, new HIPAA and Maryland reproductive health regulations, FTC breach reporting rules, and revised NIST standards WASHINGTON, DC / ...
DELRAY BEACH, FL / ACCESSWIRE / September 24, 2024 / Adolore BioTherapeutics, Inc., ("Adolore" or the "Company"), a biotechnology company developing transformational opioid-free ...
PartnershipLonza and Vertex Sign a Long-Term Commercial Supply Agreement for CASGEVY® (exagamglogene autotemcel) 24.09.2024 / 14:00 CET/CEST Lonza to manufacture CASGEVY®, the world’s first ...
Former Microsoft Technology Leader Will Oversee the Enhancement of the Company's Innovative Data Security Solutions SALT LAKE ...
New Data on Opioid Use Disorder Program at Society for Neuroscience Meeting ~~ Ensysce CEO Invited Expert Speaker at ...